Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binsah George

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|October 14, 2022
B-Lymphoid Blast Phase-Chronic Myeloid Leukemia: Current TherapeuticsBinoy Yohannan, Binsah George
Discover Oncology|January 26, 2025
Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapiesUgochi Ebinama, Binsah George
Clinical Medicine Insights. Oncology|December 12, 2022
Current Management of Chronic Myeloid Leukemia Myeloid Blast PhaseBinoy Yohanan, Binsah George
Genes|September 23, 2022
Primary Bone Marrow HIV-Associated Hodgkin Lymphoma Complicated by Hemophagocytic LymphohistiocytosisJi Lin, Binsah George
International Journal of Hematologic Oncology|March 6, 2023
Therapy-related core binding factor acute myeloid leukemiaBinsah George, Binoy Yohannan, Virginia Mohlere, et al.
Frontiers in Oncology|August 14, 2024
Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapyBinsah George, Kok Hoe Chan, Adan Rios
Immunotherapy|January 19, 2016
Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemiaBinsah George, Hagop Kantarjian, Elias Jabbour, et al.
American Journal of Clinical Oncology|December 3, 2025
Optimizing Natural Killer Cellular Therapy in Acute Myeloid LeukemiaBinsah George, Manu Pandey, Jacob Herstein, et al.
International Journal of Molecular Sciences|October 13, 2021
<i>TP53</i> in Acute Myeloid Leukemia: Molecular Aspects and Patterns of MutationBinsah George, Hagop Kantarjian, Natalia Baran, et al.
Investigational New Drugs|May 7, 2013
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancerMohamed A Khalil, Wei Qiao, Peter Carlson, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|October 14, 2022
B-Lymphoid Blast Phase-Chronic Myeloid Leukemia: Current TherapeuticsBinoy Yohannan, Binsah George
Discover Oncology|January 26, 2025
Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapiesUgochi Ebinama, Binsah George
Clinical Medicine Insights. Oncology|December 12, 2022
Current Management of Chronic Myeloid Leukemia Myeloid Blast PhaseBinoy Yohanan, Binsah George
Genes|September 23, 2022
Primary Bone Marrow HIV-Associated Hodgkin Lymphoma Complicated by Hemophagocytic LymphohistiocytosisJi Lin, Binsah George
International Journal of Hematologic Oncology|March 6, 2023
Therapy-related core binding factor acute myeloid leukemiaBinsah George, Binoy Yohannan, Virginia Mohlere, et al.
Frontiers in Oncology|August 14, 2024
Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapyBinsah George, Kok Hoe Chan, Adan Rios
Immunotherapy|January 19, 2016
Role of inotuzumab ozogamicin in the treatment of relapsed/refractory acute lymphoblastic leukemiaBinsah George, Hagop Kantarjian, Elias Jabbour, et al.
American Journal of Clinical Oncology|December 3, 2025
Optimizing Natural Killer Cellular Therapy in Acute Myeloid LeukemiaBinsah George, Manu Pandey, Jacob Herstein, et al.
International Journal of Molecular Sciences|October 13, 2021
<i>TP53</i> in Acute Myeloid Leukemia: Molecular Aspects and Patterns of MutationBinsah George, Hagop Kantarjian, Natalia Baran, et al.
Investigational New Drugs|May 7, 2013
The addition of erlotinib to gemcitabine and cisplatin does not appear to improve median survival in metastatic pancreatic cancerMohamed A Khalil, Wei Qiao, Peter Carlson, et al.
Pageof 2